Monte Rosa Therapeutics: Q2 Earnings Snapshot

About this update from Monte Rosa Therapeutics, Inc.

BOSTON (AP) — BOSTON (AP) — Monte Rosa Therapeutics Inc. (GLUE) on Thursday reported a loss of $43.4 million in its second quarter. The Boston -based company said it had a loss of 43 cents per share. The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 25 cents per share. The biopharmaceutical company posted revenue of $9 million in the period, also missing Street forecasts. Three analysts surveyed by Zacks expected $25.7 million . _____ This story was generated by Automated Insights ( http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GLUE at https://www.zacks.com/ap/GLUE For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights. , source Associated Press News

View stock analysis, news, and events for Monte Rosa Therapeutics, Inc.